Traders eyes are on ppch following a tremendous move the past week with eye-popping volume and price movement. There was absolutely no reason for the selloff of the stock over the past 6 months other than some profit taking with a huge dose of manipulation to drive the pps down to rediculous levels where we have seen massive accumulation. I believe this has been carefully orchestrated by some group of traders. When they drove the pps through the roof one year ago, there was not much substance to the move other than speculation. That however has now changed. PPCH is not setting upon a sufficient bank account to advance current studies to Phase I scheduled to be initiated in either the 3rd or 4th quarter. Mngt has a meeting now planned with the EU regulatory agency, and research is being conducted now in the US in preperation for FDA meetings some time likely in the 2nd or 3rd quarter. Traders are well aware of the immense potential for PRP as demonstrated in both stem cell research, as well as pancreatic and colorectal cancer. The fact that it has been shown to hinder and perhaps halt metastisis in utterly incredible.
This trading goup now has sufficient holding it appears they are ready to drive the pps north as Phase I and positive studies have now proven that PPCH could be on the verge of a breakthrough treatment for cancer. Fasten your seat belts people!
(2)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links